Short interest in Outlook Therapeutics Inc (NASDAQ:OTLK) decreased during the last reporting period, falling from 3.51M to 2.89M. This put 16.69% of the company's publicly available shares short.

Short interest for Outlook Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Outlook Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.24M shares traded per day, it would take 2.34 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.